Germany’s Institute for Quality and Efficiency in Health Care concluded that Columvi (glofitamab) monotherapy shows no added ...

The US regulator has issued draft guidance urging drug developers to prioritize overall survival as the primary endpoint in ...

Washington, USA-based immunotherapy specialist Adaptive Biotechnologies (Nasdaq: ADPT) said Monday that its strategic ...

In a significant shift for the US pharmaceutical landscape, President Donald Trump has formally announced in May 2025, a push ...

Shares of San Diego, USA-based Viking Therapeutics tumbled 43% to $23.50 by mid-morning after the company released mid-stage ...

Shanghai Henlius Biotech today revealed it has entered into a strategic collaboration with fellow Chinese drug developer ...

Heidelberg, Germany-based research institute BioMed X announced a new collaboration with Denmark’s Novo Nordisk, which aims ...

Privately-held US biotech Skyhawk Therapeutics has announced a strategic research collaboration with Germany’s Merck KGaA ...

Australian biotech CSL Limited today reported net profit after tax of US$3.0 billion for the 12 months ended June 30, 2025, ...

Clinical research provider IQVIA and Veeva System have announced global clinical and commercial partnerships and the complete ...

GoodRx (Nasdaq: GDRX) has teamed up with Novo Nordisk (NOV: N) to make all dose levels of Ozempic (semaglutide) and Wegovy ...

Merck & Co (NYSE: MRK) and Daiichi Sankyo (TYO: 4568) have received Breakthrough Therapy designation from the US regulator ...